4. Subjects who received radiation therapy within 2 weeks of study randomization (C1D1) (If subjects completed local radiation therapy as palliative care to alleviate pain on non- target lesions (e.g. sites of bone metastasis) and was recovered from relevant acute toxicity (e.g. bone marrow suppression), they are eligible for the study